Holen Sie sich die Stockscreener-App
4.62
0.65%
0.03
Handel nachbörslich:
4.62
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
BlackRock (NYSE: CTKB) holds 7.2% — 9.36M shares of Cytek Biosciences - Stock Titan
Cytek Biosciences expands flow cytometry footprint amid growing immunology demand - ad-hoc-news.de
CTKBCytek BioSciences Inc Latest SEC Filings - Finviz
If You Invested $1,000 in Cytek Biosciences, Inc. (CTKB) - Stock Titan
Cytek Biosciences explores growth paths as investors weigh long-term potential - ad-hoc-news.de
Cytek Biosciences (CTKB) Edges Higher as Shares Stabilize Near SupportTICK Divergence - dars.gov.et
June 2026 Penny Stocks With Promising Potential - Sahm
Cytek Biosciences (NASDAQ: CTKB) adds Chief Legal Officer as reporting insider - Stock Titan
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from Russell 2000 Defensive Index - marketscreener.com
Enterprise value to revenue forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Price to earnings forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Enterprise value to EBIT forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Price to sales forward of Cytek Biosciences, Inc. – NASDAQ:CTKB - TradingView
Cytek Biosciences, Inc.(NasdaqGS:CTKB) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Enterprise value to revenue forward of Cytek Biosciences, Inc. – BOATS:CTKB - TradingView
CTKB Forecast — Price Target — Prediction for 2027 - TradingView
8EQ Forecast — Price Target — Prediction for 2027 - TradingView
Cytek Biosciences, Inc. Actuals & Estimates (NASDAQ:CTKB) - TradingView
Cytek Biosciences Announces Chief Legal Officer Transition - The Globe and Mail
Cytek Biosciences, Inc. Actuals & Estimates (GETTEX:8EQ) - TradingView
Cytek Biosciences' Valerie Barnett to Depart as Chief Legal Officer and Corporate Secretary - TradingView
Cytek Biosciences (NASDAQ: CTKB) legal chief exit detailed - Stock Titan
Cytek Biosciences, Inc. Announces Termination of Valerie Barnett as Chief Legal Officer and Corporate Secretary, Effective June 29, 2026 - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P 1000 - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P 600 Health Care - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P Composite 1500 - marketscreener.com
Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P 600 - marketscreener.com
Cytek Biosciences Inc (CTKB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cytek Biosciences Stockholders Back Board, Pay and Auditor - The Globe and Mail
Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets - Yahoo Finance
Cytek Biosciences Inc (CTKB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cytek Biosciences Inc (CTKB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cytek Biosciences Inc (CTKB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cytek Biosciences shareholders elect directors and approve key proposals at annual meeting By Investing.com - Investing.com South Africa
Cytek Biosciences shareholders elect directors and approve key proposals at annual meeting - Investing.com Canada
Cytek Biosciences launches quick reference guide to streamline lab use of cFluor dyes - Traders Union
Cytek Biosciences Inc (CTKB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cytek Biosciences (CTKB) CTO Yan Ming reports bona fide gift of shares - Stock Titan
Cytek Biosciences Inc (CTKB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cytek Biosciences (CTKB) details 2026 shareholder meeting voting outcomes - Stock Titan
Cytek Biosciences Inc (CTKB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cytek Biosciences Inc (CTKB) Institutional Confidence - TradingKey
Cytek Biosciences (CTKB) Singular Research’s Las Vegas Invitational Conference summary - Quartr
Cytek Biosciences, Inc. (CTKB) Presents at Singular Research's Las Vegas Invitational ConferenceSlideshow - Seeking Alpha
Cytek Biosciences (CTKB) director converts 43,973 RSUs to common stock - Stock Titan
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Cytek Biosciences (CTKB) director Glenn Muir files initial ownership report - Stock Titan
Cytek Biosciences (CTKB) director awarded 18,261 options plus 33,333 RSUs - Stock Titan
Cytek Biosciences (CTKB) director boosts stake with RSU exercise and new option, RSU grants - Stock Titan
Cytek Biosciences (CTKB) director exercises RSUs and receives new equity awards - Stock Titan
Cytek Biosciences (CTKB) director exercises 43,973 RSUs, granted options and RSUs - Stock Titan
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference - GlobeNewswire
Cytek Biosciences debuts Borealis spectral cytometer - Select Science
Cytek Biosciences Shares Fall After Borealis News and Sales Exit - Bez Kabli
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026 - BioSpace
Cytek Biosciences Announces Resignation of Senior Sales Executive - TipRanks
Cytek Biosciences' Philippe Busque resigns as Senior VP, Global Sales and Services - TradingView
Cytek Biosciences, Inc. Announces Resignation of Philippe Busque from Senior Vice President, Global Sales and Services, Effective June 5, 2026 - marketscreener.com
Cytek Biosciences (CTKB) SVP Global Sales and Services to step down June 5, 2026 - Stock Titan
Cytek Biosciences explores new vaccine strategies targeting mucosal immunity - Traders Union
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):